Drug Profile
Gentamicin topical - Royer Biomedical
Alternative Names: AppliGel-G; Gentamicin Sulfate Topical GelLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Royer Biomedical
- Class Aminoglycosides; Anti-infectives; Antibacterials; Small molecules
- Mechanism of Action Protein 30S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Diabetic foot ulcer
Most Recent Events
- 13 May 2015 Royer Biomedical terminates a phase I/II trial in Diabetic foot ulcer in USA (Topical) (NCT02036528)
- 01 Jan 2014 Phase-I/II clinical trials in Diabetic foot ulcer in USA (Topical)
- 25 May 2012 US FDA approves IND application for Royer Biomedical's topical gentamicin in diabetic foot ulcer